Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927639 · ClinicalTrials.gov registry record · NA
MyDiaText Text Messaging Intervention for Diabetes
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT02927639 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 166 participants.
The verdict
NCT02927639, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
To test a text messaging intervention using MyDiaText and financial incentives to determine whether such an intervention will improve self-reported self-care behaviors in children 12 to 18 years old. The intervention will consist of daily text messages sent to the subject's personal mobile device. Subjects will be incentivized to respond to text messages via a lottery financial incentive. Previously developed text messages based on the American Diabetes Association (ADA) behavior goals will be used for this intervention.
Interventions
- OTHER MyDiaText
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2019-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02927639
The ClinicalTrials.gov registry entry for NCT02927639 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MyDiaText is the first listed.
NCT02927639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02927639 about?
NCT02927639 is a clinical study titled "MyDiaText Text Messaging Intervention for Diabetes". To test a text messaging intervention using MyDiaText and financial incentives to determine whether such an intervention will improve self-reported self-care behaviors in children 12 to 18 years old. The intervention will consist of daily text messages sent to the subject's personal mobile device. S...
What is the current status of trial NCT02927639?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2018-07-31. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT02927639?
The interventions under investigation include: MyDiaText (OTHER).
Who is sponsoring clinical trial NCT02927639?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.